PDB Short entry for 2LAV HEADER TRANSFERASE 21-MAR-11 2LAV TITLE NMR SOLUTION STRUCTURE OF HUMAN VACCINIA-RELATED KINASE 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: VACCINIA-RELATED KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SERINE/THREONINE-PROTEIN KINASE VRK1; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: VRK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET29B KEYWDS VRK1, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, MITOSIS, CELL KEYWDS 2 CYCLE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR J.SHIN,H.S.YOON REVDAT 4 14-JUN-23 2LAV 1 REMARK REVDAT 3 06-JUL-11 2LAV 1 JRNL REVDAT 2 18-MAY-11 2LAV 1 JRNL REVDAT 1 04-MAY-11 2LAV 0 JRNL AUTH J.SHIN,G.CHAKRABORTY,N.BHARATHAM,C.KANG,N.TOCHIO,S.KOSHIBA, JRNL AUTH 2 T.KIGAWA,W.KIM,K.T.KIM,H.S.YOON JRNL TITL NMR SOLUTION STRUCTURE OF HUMAN VACCINIA-RELATED KINASE 1 JRNL TITL 2 (VRK1) REVEALS THE C-TERMINAL TAIL ESSENTIAL FOR ITS JRNL TITL 3 STRUCTURAL STABILITY AND AUTOCATALYTIC ACTIVITY. JRNL REF J.BIOL.CHEM. V. 286 22131 2011 JRNL REFN ISSN 0021-9258 JRNL PMID 21543316 JRNL DOI 10.1074/JBC.M110.200162 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE, CNS 1.2 REMARK 3 AUTHORS : DELAGLIO, GRZESIEK, VUISTER, ZHU, PFEIFER AND BAX REMARK 3 (NMRPIPE), BRUNGER, ADAMS, CLORE, GROS, NILGES AND REMARK 3 READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LAV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1000102171. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.8 REMARK 210 IONIC STRENGTH : 20 REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 0.3-0.5 MM [U-100% 13C; U-100% REMARK 210 15N; U-80% 2H] VACCINIA RELATED- REMARK 210 KINASE 1, 0.3-0.5 MM [U-100% 15N; REMARK 210 U-50% 2H] VACCINIA RELATED- REMARK 210 KINASE 1, 0.1-0.2 MM [U-100% 15N] REMARK 210 VACCINIA RELATED-KINASE 1, 90% REMARK 210 H2O/10% D2O; 0.3-0.5 MM [U-100% REMARK 210 13C; U-100% 15N; U-70% 2H] REMARK 210 VACCINIA RELATED-KINASE 1, 0.3- REMARK 210 0.5 MM [13C;15N]-VAL,ILE,LEU; [U- REMARK 210 100% 2H] VACCINIA RELATED-KINASE REMARK 210 1, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCACB; 3D REMARK 210 HN(COCA)CB; 3D HNCO; 3D HN(CO)CA; REMARK 210 3D HN(CA)CO; 3D 1H-15N NOESY; REMARK 210 3D 1H-13C NOESY; 3D HCCH-TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ; 800 MHZ; 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY, CYANA REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 13 -61.48 -160.61 REMARK 500 1 LYS A 16 175.76 60.56 REMARK 500 1 LEU A 19 112.32 61.02 REMARK 500 1 ASP A 31 172.86 -57.74 REMARK 500 1 ASN A 57 88.81 -58.15 REMARK 500 1 SER A 58 -76.83 -108.19 REMARK 500 1 SER A 59 -173.15 -179.38 REMARK 500 1 GLU A 60 -165.09 43.92 REMARK 500 1 LYS A 106 -77.17 -82.75 REMARK 500 1 LYS A 179 171.30 -54.33 REMARK 500 1 ASP A 197 76.35 59.60 REMARK 500 1 LEU A 200 31.58 -176.63 REMARK 500 1 CYS A 205 57.65 -143.58 REMARK 500 1 TYR A 213 89.74 -57.31 REMARK 500 1 ASP A 216 64.89 -154.98 REMARK 500 1 PHE A 227 29.28 -157.06 REMARK 500 1 TRP A 261 45.25 -96.85 REMARK 500 1 ASN A 264 36.12 -151.79 REMARK 500 1 ASN A 281 77.70 -114.17 REMARK 500 1 ASN A 294 93.35 -167.66 REMARK 500 1 LEU A 308 31.32 -96.14 REMARK 500 1 LEU A 316 72.38 -112.10 REMARK 500 1 ASP A 335 92.34 -58.37 REMARK 500 1 LYS A 338 -167.33 64.16 REMARK 500 1 LEU A 339 74.04 -67.72 REMARK 500 1 LEU A 341 46.61 -143.49 REMARK 500 1 VAL A 343 -36.21 -157.43 REMARK 500 1 VAL A 344 136.01 82.07 REMARK 500 1 GLU A 345 76.39 176.38 REMARK 500 1 ALA A 351 99.14 -163.00 REMARK 500 1 THR A 353 -44.26 -160.65 REMARK 500 1 ILE A 354 175.23 -47.64 REMARK 500 1 THR A 355 80.80 -154.04 REMARK 500 1 LYS A 356 57.45 -176.39 REMARK 500 1 ARG A 358 -65.86 -162.83 REMARK 500 1 LYS A 360 86.83 60.62 REMARK 500 2 ARG A 3 -60.06 -106.14 REMARK 500 2 ALA A 7 -46.45 -154.25 REMARK 500 2 GLN A 8 107.32 60.34 REMARK 500 2 ARG A 11 103.62 60.27 REMARK 500 2 GLN A 12 -44.17 -164.77 REMARK 500 2 SER A 14 -51.25 -140.86 REMARK 500 2 ALA A 15 -69.28 -172.81 REMARK 500 2 LYS A 16 32.09 -164.64 REMARK 500 2 LEU A 19 -42.23 -171.11 REMARK 500 2 ALA A 20 174.77 -59.12 REMARK 500 2 GLU A 21 76.31 -179.13 REMARK 500 2 GLN A 22 -75.49 -176.34 REMARK 500 2 PHE A 48 -77.78 65.20 REMARK 500 2 ASN A 57 98.86 -59.35 REMARK 500 REMARK 500 THIS ENTRY HAS 788 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 16715 RELATED DB: BMRB DBREF 2LAV A 1 361 UNP Q99986 VRK1_HUMAN 1 361 SEQRES 1 A 361 MET PRO ARG VAL LYS ALA ALA GLN ALA GLY ARG GLN SER SEQRES 2 A 361 SER ALA LYS ARG HIS LEU ALA GLU GLN PHE ALA VAL GLY SEQRES 3 A 361 GLU ILE ILE THR ASP MET ALA LYS LYS GLU TRP LYS VAL SEQRES 4 A 361 GLY LEU PRO ILE GLY GLN GLY GLY PHE GLY CYS ILE TYR SEQRES 5 A 361 LEU ALA ASP MET ASN SER SER GLU SER VAL GLY SER ASP SEQRES 6 A 361 ALA PRO CYS VAL VAL LYS VAL GLU PRO SER ASP ASN GLY SEQRES 7 A 361 PRO LEU PHE THR GLU LEU LYS PHE TYR GLN ARG ALA ALA SEQRES 8 A 361 LYS PRO GLU GLN ILE GLN LYS TRP ILE ARG THR ARG LYS SEQRES 9 A 361 LEU LYS TYR LEU GLY VAL PRO LYS TYR TRP GLY SER GLY SEQRES 10 A 361 LEU HIS ASP LYS ASN GLY LYS SER TYR ARG PHE MET ILE SEQRES 11 A 361 MET ASP ARG PHE GLY SER ASP LEU GLN LYS ILE TYR GLU SEQRES 12 A 361 ALA ASN ALA LYS ARG PHE SER ARG LYS THR VAL LEU GLN SEQRES 13 A 361 LEU SER LEU ARG ILE LEU ASP ILE LEU GLU TYR ILE HIS SEQRES 14 A 361 GLU HIS GLU TYR VAL HIS GLY ASP ILE LYS ALA SER ASN SEQRES 15 A 361 LEU LEU LEU ASN TYR LYS ASN PRO ASP GLN VAL TYR LEU SEQRES 16 A 361 VAL ASP TYR GLY LEU ALA TYR ARG TYR CYS PRO GLU GLY SEQRES 17 A 361 VAL HIS LYS GLU TYR LYS GLU ASP PRO LYS ARG CYS HIS SEQRES 18 A 361 ASP GLY THR ILE GLU PHE THR SER ILE ASP ALA HIS ASN SEQRES 19 A 361 GLY VAL ALA PRO SER ARG ARG GLY ASP LEU GLU ILE LEU SEQRES 20 A 361 GLY TYR CYS MET ILE GLN TRP LEU THR GLY HIS LEU PRO SEQRES 21 A 361 TRP GLU ASP ASN LEU LYS ASP PRO LYS TYR VAL ARG ASP SEQRES 22 A 361 SER LYS ILE ARG TYR ARG GLU ASN ILE ALA SER LEU MET SEQRES 23 A 361 ASP LYS CYS PHE PRO GLU LYS ASN LYS PRO GLY GLU ILE SEQRES 24 A 361 ALA LYS TYR MET GLU THR VAL LYS LEU LEU ASP TYR THR SEQRES 25 A 361 GLU LYS PRO LEU TYR GLU ASN LEU ARG ASP ILE LEU LEU SEQRES 26 A 361 GLN GLY LEU LYS ALA ILE GLY SER LYS ASP ASP GLY LYS SEQRES 27 A 361 LEU ASP LEU SER VAL VAL GLU ASN GLY GLY LEU LYS ALA SEQRES 28 A 361 LYS THR ILE THR LYS LYS ARG LYS LYS GLU HELIX 1 1 GLY A 78 ALA A 91 1 14 HELIX 2 2 LYS A 92 LYS A 104 1 13 HELIX 3 3 ASP A 137 ASN A 145 1 9 HELIX 4 4 SER A 150 GLU A 170 1 21 HELIX 5 5 LYS A 179 SER A 181 5 3 HELIX 6 6 CYS A 205 VAL A 209 5 5 HELIX 7 7 SER A 229 GLY A 235 1 7 HELIX 8 8 ARG A 240 GLY A 257 1 18 HELIX 9 9 LEU A 259 ASP A 263 5 5 HELIX 10 10 ASP A 267 ASN A 281 1 15 HELIX 11 11 ASN A 281 PHE A 290 1 10 HELIX 12 12 PRO A 296 LEU A 308 1 13 HELIX 13 13 LEU A 316 ILE A 331 1 16 SHEET 1 A 6 GLU A 27 THR A 30 0 SHEET 2 A 6 GLU A 36 ILE A 43 -1 O VAL A 39 N GLU A 27 SHEET 3 A 6 ILE A 51 MET A 56 -1 O ILE A 51 N ILE A 43 SHEET 4 A 6 CYS A 68 PRO A 74 -1 O VAL A 70 N TYR A 52 SHEET 5 A 6 LYS A 124 ASP A 132 -1 O MET A 131 N VAL A 69 SHEET 6 A 6 TYR A 113 LYS A 121 -1 N GLY A 115 O ILE A 130 SHEET 1 B 2 LEU A 183 LEU A 185 0 SHEET 2 B 2 VAL A 193 LEU A 195 -1 O TYR A 194 N LEU A 184 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000